FDA Clearance Tracker · P030027-S005
Ceramic Transcend® Hip Articulation System
Last checked: Nov 20, 2026Latest source record: Feb 16, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Feb 16, 2018
Approved
Time to decision
2,200 days
Received Feb 8, 2012. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P030027-S005
- Device name
- Ceramic Transcend® Hip Articulation System
- Applicant
- Microport Orthopedics, Inc.
- Applicant location
- Arlington, TN
- Received
- Feb 8, 2012
- Decided
- Feb 16, 2018
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - PAS
- Original approval
- P030027
Device type
- Device type
- Prosthesis, hip, semi-constrained, metal/ceramic/ceramic/metal, cemented or uncemented (MRA)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval of product labeling which was updated after the completion of post-approval study protocol.
Source documents
Other decisions for Microport Orthopedics, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- NEXUS® Hip Stem510(k)
K262473 · Decided Oct 1, 2026 · 76 days after receipt
Device type: Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Cemented Or Non-Porous, Uncemented (LZO) · Orthopedic Surgery
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.